Yu Zhang1,2, Hanjie Xu3, Yusheng Liu1, Shengxia Zheng1, Weidong Zhao3, Dabao Wu3, Lei Lei3, Gang Chen3. 1. Division of Life Sciences and Medicine, Department of Reproductive Medicine Center, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China. 2. Department of Obstetrics and Gynecology, Anhui Women and Child Health Care Hospital, Anhui Medical University, Hefei, China. 3. Division of Life Sciences and Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.
Abstract
PROBLEM: The aim of this prospective study was to investigate the prevalence of chronic endometritis (CE) in repeated implantation failure (RIF) patients and to determine whether intrauterine delivery of the combined administration of antibiotic and dexamethasone improves the clinical pregnancy outcome. METHOD OF STUDY: The combination of hysteroscopy and histology was used to diagnose CE in the patients with RIF, and the diagnosed patients were treated with the intrauterine delivery of the combined antibiotic and dexamethasone therapy. The prevalence of CE in the RIF patients was recorded, and the therapeutic effect was also evaluated in the first IVF-ET cycle. RESULTS: In a total number of 298 patients with RIF, 109 cases (36.58%) were diagnosed as CE. Intrauterine infusion treatment resulted in CE resolution in 77.98% of patients. After the treatment, 85 cases with no signs of CE (Group 2) had a significantly higher implantation rate (31.33%) and clinical pregnancy rate (51.76%) as compared with both 126 cases without CE diagnosis (Group 1; 16.30% and 30.15%, respectively) and 24 cases with persistence of CE (Group 3; 14.89% and 25.00%, respectively). The live birth rate in the first IVF-ET cycle following treatment in Group 2 was significantly higher than that of both Group 1 and Group 3 (all P < .05). CONCLUSION: Chronic endometritis is highly prevalent in patients with RIF. To the best of our knowledge, we for the first time reported that intrauterine delivery of the combined administration of antibiotic and dexamethasone as a treatment option of CE could achieve expected therapeutic effects and successful pregnancy outcomes.
PROBLEM: The aim of this prospective study was to investigate the prevalence of chronic endometritis (CE) in repeated implantation failure (RIF) patients and to determine whether intrauterine delivery of the combined administration of antibiotic and dexamethasone improves the clinical pregnancy outcome. METHOD OF STUDY: The combination of hysteroscopy and histology was used to diagnose CE in the patients with RIF, and the diagnosed patients were treated with the intrauterine delivery of the combined antibiotic and dexamethasone therapy. The prevalence of CE in the RIF patients was recorded, and the therapeutic effect was also evaluated in the first IVF-ET cycle. RESULTS: In a total number of 298 patients with RIF, 109 cases (36.58%) were diagnosed as CE. Intrauterine infusion treatment resulted in CE resolution in 77.98% of patients. After the treatment, 85 cases with no signs of CE (Group 2) had a significantly higher implantation rate (31.33%) and clinical pregnancy rate (51.76%) as compared with both 126 cases without CE diagnosis (Group 1; 16.30% and 30.15%, respectively) and 24 cases with persistence of CE (Group 3; 14.89% and 25.00%, respectively). The live birth rate in the first IVF-ET cycle following treatment in Group 2 was significantly higher than that of both Group 1 and Group 3 (all P < .05). CONCLUSION:Chronic endometritis is highly prevalent in patients with RIF. To the best of our knowledge, we for the first time reported that intrauterine delivery of the combined administration of antibiotic and dexamethasone as a treatment option of CE could achieve expected therapeutic effects and successful pregnancy outcomes.
Authors: S Pereira; S Carmi; G Altarescu; J Austin; D Barlevy; A Hershlag; E Juengst; K Kostick-Quenet; E Kovanci; R B Lathi; M Mukherjee; I Van den Veyver; O Zuk; G Lázaro-Muñoz; T Lencz Journal: Hum Reprod Date: 2022-06-30 Impact factor: 6.353
Authors: Maximilian Murtinger; Barbara Wirleitner; Dietmar Spitzer; Helena Bralo; Susanna Miglar; Maximilian Schuff Journal: Hum Reprod Open Date: 2022-06-07
Authors: Nerea M Molina; Alberto Sola-Leyva; Maria Jose Saez-Lara; Julio Plaza-Diaz; Aleksandra Tubić-Pavlović; Barbara Romero; Ana Clavero; Juan Mozas-Moreno; Juan Fontes; Signe Altmäe Journal: Biomolecules Date: 2020-04-11
Authors: Vera R Mitter; Sheila Meier; Tilman T Rau; Tessa Gillon; Michael D Mueller; Marcel Zwahlen; Michael von Wolff; Alexandra S Kohl Schwartz Journal: Am J Reprod Immunol Date: 2021-08-09 Impact factor: 3.886